NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.

Cover of Drugs and Lactation Database (LactMed)

Drugs and Lactation Database (LactMed) [Internet].

Show details

Dacomitinib

Last Revision: December 3, 2018.

Estimated reading time: 1 minute

CASRN: 1110813-31-4

Chemical structure

Drug Levels and Effects

Summary of Use during Lactation

No information is available on the clinical use of dacomitinib during breastfeeding. Because dacomitinib is 98% bound to plasma proteins, the amount in milk is likely to be low. However, because of its potential toxicity in the breastfed infant and its half-life of 70 hours, the manufacturer recommends that breastfeeding be discontinued during dacomitinib therapy and for at least 17 days after the last dose.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Dacomitinib

CAS Registry Number

1110813-31-4

Drug Class

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Tyrosine Kinase Inhibitors
  • Breast Feeding

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Views

Related information

Similar articles in PubMed

  • Review Afatinib[Drugs and Lactation Database (...]
    Review Afatinib
    . Drugs and Lactation Database (LactMed). 2006
  • Review Crizotinib[Drugs and Lactation Database (...]
    Review Crizotinib
    . Drugs and Lactation Database (LactMed). 2006
  • Review Vandetanib[Drugs and Lactation Database (...]
    Review Vandetanib
    . Drugs and Lactation Database (LactMed). 2006
  • Review Neratanib[Drugs and Lactation Database (...]
    Review Neratanib
    . Drugs and Lactation Database (LactMed). 2006
  • Review Gefitinib[Drugs and Lactation Database (...]
    Review Gefitinib
    . Drugs and Lactation Database (LactMed). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...